Literature DB >> 2710189

Familial clustering of diabetic kidney disease. Evidence for genetic susceptibility to diabetic nephropathy.

E R Seaquist1, F C Goetz, S Rich, J Barbosa.   

Abstract

Diabetic nephropathy develops in less than half of all patients with diabetes. To study heredity as a possible risk factor for diabetic kidney disease, we examined the concordance rates for diabetic nephropathy in two sets of families in which both probands and siblings had diabetes mellitus. In one set, the probands (n = 11) had no evidence of diabetic nephropathy, with normal creatinine clearance and a urinary albumin excretion rate below 45 mg per day. In the other set, the probands (n = 26) had undergone kidney transplantation because of diabetic nephropathy. Evidence of nephropathy was found in 2 of the 12 diabetic siblings of the probands without nephropathy (17 percent). Of the 29 diabetic siblings of probands with diabetic nephropathy, 24 (83 percent) had evidence of nephropathy (P less than 0.001), including 12 with end-stage renal disease. No significant differences were noted between the sibling groups with respect to the duration of diabetes, blood pressure, glycemic control, or glycosylated hemoglobin levels. Logistic regression analysis found nephropathy in the proband to be the only factor significantly predictive of the renal status of the diabetic sibling. We conclude that diabetic nephropathy occurs in familial clusters. This is consistent with the hypothesis that heredity helps to determine susceptibility to diabetic nephropathy. However, this study cannot rule out the possible influences of environmental factors shared by siblings.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2710189     DOI: 10.1056/NEJM198905043201801

Source DB:  PubMed          Journal:  N Engl J Med        ISSN: 0028-4793            Impact factor:   91.245


  204 in total

Review 1.  Is it possible to predict diabetic kidney disease?

Authors:  S M Thomas; G C Viberti
Journal:  J Endocrinol Invest       Date:  2000-01       Impact factor: 4.256

Review 2.  Progress in Defining the Genetic Basis of Diabetic Complications.

Authors:  Emma Dahlström; Niina Sandholm
Journal:  Curr Diab Rep       Date:  2017-09       Impact factor: 4.810

3.  Genetic variation in the matrix metalloproteinase genes and diabetic nephropathy in type 1 diabetes.

Authors:  Masahiko Kure; Marcus G Pezzolesi; G David Poznik; Pisut Katavetin; Jan Skupien; Jonathon S Dunn; Josyf C Mychaleckyj; James H Warram; Andrzej S Krolewski
Journal:  Mol Genet Metab       Date:  2011-01-14       Impact factor: 4.797

4.  Role of the ACE ID and PPARG P12A Polymorphisms in Genetic Susceptibility of Diabetic Nephropathy in a South Indian Population.

Authors:  Lakkakula Vks Bhaskar; Sultana Mahin; Raju Thankabai Ginila; Periyasamy Soundararajan
Journal:  Nephrourol Mon       Date:  2013-05-26

Review 5.  Risk predictors in patients with diabetic nephropathy.

Authors:  P Fioretto; M L Caramori; M Dalla Vestra; M Mauer
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

Review 6.  The relationship between glucose control and the development and progression of diabetic nephropathy.

Authors:  Carrie A Phillips; Mark E Molitch
Journal:  Curr Diab Rep       Date:  2002-12       Impact factor: 4.810

Review 7.  Genetics of diabetic nephropathy in the Pima Indians.

Authors:  G Imperatore; W C Knowler; R G Nelson; R L Hanson
Journal:  Curr Diab Rep       Date:  2001-12       Impact factor: 4.810

Review 8.  Genetics of diabetes complications.

Authors:  Donald W Bowden
Journal:  Curr Diab Rep       Date:  2002-04       Impact factor: 4.810

9.  Silent diabetic nephropathy.

Authors:  Katia López-Revuelta; Patricia Peña Galdo; Ramona Stanescu; Leticia Parejo; Carmen Guerrero; Elia Pérez-Fernández
Journal:  World J Nephrol       Date:  2014-02-06

10.  Development and progression of microalbuminuria in a clinic sample of patients with insulin dependent diabetes mellitus.

Authors:  C A Jones; G P Leese; S Kerr; K Bestwick; D I Isherwood; J P Vora; D A Hughes; C Smith
Journal:  Arch Dis Child       Date:  1998-06       Impact factor: 3.791

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.